1-Choe S, Bennett MJ, Fujii G, Curmi PMG, Kantardjieff KA, Collier RJ, et al. The crystal structure of diphtheria toxin. Nature. 1992;357(6375):216-22.
2-Requirements for diphtheria, tetanus, pertussis and combined vaccines. WHO Expert Committee on Biological Standardization Fortieth Report Geneva, World Health Organization. 1990.
3-Manual for quality control of diphtheria, tetanus and pertussis vaccines. WHO. 2013.
4-Recommendations to assure the quality, safety and efficacy of DT-based combined vaccines. WHO. 2012.
5-Uchida T, Pappenheimer AM, Greany R. Diphtheria toxin and related proteins I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. Journal of Biological Chemistry. 1973;248(11):3838-44.
6-Ouchterlony O. In vitro method for testing the toxin‐producing capacity of diphtheria bacteria. APMIS. 1948;25(1‐2):186-91.
7-Kempken R, Preissmann A, Berthold W. Assessment of a disc stack centrifuge for use in mammalian cell separation. Biotechnology and bioengineering. 1995;46(2):132-8.
8-UDAYA BHASKARA RAO Y, Mahadevan M, Michaels S. Evaluation of microporous tangential-flow filtration in the production of Diphtheria and Pertussis vaccines. Pharmaceutical technology. 1992;16(9):102-.
9-Besnard L, Fabre V, Fettig M, Gousseinov E, Kawakami Y, Laroudie N, et al. Clarification of vaccines: An overview of filter based technology trends and best practices. Biotechnology advances. 2016;34(1):1-13.
10-Sundaran B, Palaniappan C, Rao YUB, Boopathy R, Bhau LNR. Tangential flow filtration technology applicable to large scale recovery of diphtheria toxin. Journal of bioscience and bioengineering. 2002;94(2):93-8
11-Ulmer JB, Valley U, Rappuoli R. Vaccine manufacturing: challenges and solutions. Nature biotechnology. 2006;24(11):1377-83.
12-Zanders ED. Commercial Aspects of Drug Development. The Science and Business of Drug Discovery: Springer; 2011. p. 305-28.
)